• New Enzymatic Assay is Launched.

Laboratory Products

New Enzymatic Assay is Launched.

Oct 02 2006

Axis-Shield UK has launched the Enzymatic Homocysteine Assay, an in vitro diagnostic assay for quantitative measurement of total homocysteine in human serum and plasma. Studies show that homocysteine is harmful when excess amounts accumulate in the blood stream, damaging arterial vessels and causing inflammation, potentially resulting in a blockage. Protocols are available for using Axis-Shield's Enzymatic Homocysteine Assay on all commonly found clinical chemistry platforms. Reagents are stable on board the chosen instrument for up to 30 days.

Recent research provides evidence that elevated blood levels of homocysteine have a predictive value for risk of coronary artery disease, similar to that of elevated cholesterol levels. Elevated levels have also been implicated in miscarriages and birth defects.

Homocysteine is a by-product of protein metabolism, specifically the breakdown of the essential amino acid, methionine. It is not by itself incorporated into proteins but is further broken down by enzymes into cysteine or is converted back to methionine. Low concentrations are not harmful to the body.

Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions



Apr 22 2024 Marrakech, Morroco

Korea Lab 2024

Apr 23 2024 Kintex, South Korea

Korea Chem 2024

Apr 23 2024 Seoul, South Korea

Lab Indonesia

Apr 24 2024 Jakarta, Indonesia

View all events